Active, Not Recruiting
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
NCT05575167
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- Univ. Lille, CHU Lille Lille, France
- 251 Hellenic Airforce and VA General Hospital Athens, Greece
- First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens Athens, Greece
- , KAT General Hospital Athens, Greece